the contribution of PSCs to the target organ is key to the method's success. However, the contribution rate of PSCs in target organs generated by different chimeric animal generation methods remains unknown. In this study, we used 8-cell embryo aggregation, 8-cell embryo injection, and blastocyst injection to generate interspecies chimeric mice using rat embryonic stem (ES) cells and then investigated the differences in the contribution rate of the rat ES cells. The rate of chimeric mouse generation was the highest using blastocyst injection, followed in order by 8-cell embryo injection and 8-cell embryo aggregation. However, the contribution rate of rat ES cells was the highest in chimeric neonates generated by 8-cell embryo injection, and the difference was statistically significant in the liver. Live functionality was confirmed by analyzing the expression of rat hepatocyte-derived drug-metabolizing enzyme.
Collectively, these findings indicate that the 8-cell embryo injection method is the most suitable for generation of PSC-derived organs via chimeric animal generation, particularly for the liver.
K E Y W O R D S
blastocyst complementation, chimeric animal generation, liver generation, xenogeneic chimera printers and co-culture of liver buds with hepatocytes, vascular endothelial cells, and mesenchymal stem cells. [4] [5] [6] [7] [8] However, the organs generated by these methods are immature with insufficient function.
To address these problems, researchers have turned to generating organs in vivo using the blastocyst complementation method. [9] [10] [11] In blastocyst complementation, embryos that are unable to form specific organs (such as the pancreas or kidney) are combined at the blastocyst stage with PSCs that are competent to form those organs.
Significantly, a recent study used blastocyst complementation to successfully generate mouse pancreatic islets in rats, which demonstrated a therapeutic effect when transplanted into diabetic mice. 12 Furthermore, the contribution of human iPS cells to porcine embryos has been reported, and it is expected that human organs will be produced in xenogeneic animals in the future. 13 The complementation method can likely be applied to other organs, such as the liver-this would not only improve regenerative therapies but also drug development, which currently suffers from the lack of human hepatocytes.
The blastocyst complementation method is based on blastocyst injection, a method of generating chimeric animals that combines fertilized eggs and pluripotent stem cells (PSCs) such as ES or iPS cells. Chimeric animals can be generated in two ways: by injection of PSCs into early embryos at either the 8-cell or blastocyst stage 14 or through the aggregation method, in which PSCs are co-cultured with two fertilized eggs. 15, 16 The injection method can strictly adjust the number of cells to be injected, but specialized equipment is needed.
Although the aggregation method requires less equipment and is easier to operate, it has the disadvantage that the embryo development stages that can be used are limited. Both methods have been widely used to generate transgenic mice, and differences in the generation and germ-line transmission efficiency have been reported for each method. 17 It was reported that the germ-line transmission efficiency of chimeric animals increased by using 8-cell embryos.
The contribution ratio of PSC-derived cells is considered to be the most important factor when generating interspecies chimeric animals such as pig-human chimeras for regenerative therapy.
Recently, it has been reported that heterogeneous chimeric mice can be produced not only by blastocyst injection but also by the aggregation method. 18 However, the differences in the relative generation efficiency and contribution ratios of PSCs-derived cells in each organ by chimeric mouse generation method have not been studied. Therefore, in this study, we investigated the differences in the contribution ratios of rat-derived ES cells in a number of organs in chimeric mice generated using three different methods: the 8-cell 
| MATERIAL S AND ME THODS

| Animals
Female B6D2F1 mice, female ICR mice, and male C57BL/6 mice were purchased from SLC Japan Inc. (Tokyo, Japan). The animals were housed in a controlled environment with access to water ad libitum. All experimental procedures conformed to the Regulations for Animal Experimentation at Nagoya City University and were reviewed by the Institutional Laboratory Animal Care and Use
Committee of Nagoya City University, and finally approved by the President of University.
| Culture of rat ES cells
The RT2 rat ES cell line (RGD ID: 10054032) expressing tdTOMATO gene was used for chimera production. 19 Briefly, rat ES cells were cultured on mitomycin C-treated mouse embryonic fibroblasts
10 μmol/L Forskolin (Wako), and 1000 U/mL of rat leukemia inhibitory factor (Millipore, Bedford, MA). The medium was changed every day.
| Isolation of mouse embryos
Female 4-to 7-week-old B6D2F1 mice were superovulated by intraperitoneal injection of 7.5 IU pregnant mare serum gonadotropin (PMS), followed by injection of 7.5 IU human chorionic gonadotropin (hCG) 48 h later. After injection of hCG, the B6D2F1 mice were mated with male C57BL/6 mice. Mated B6D2F1 mice were euthanized under anesthesia at 2.5 (about 56 hours after hCG injection) and 3.5 (about 87 hours after hCG injection) days post-coitum (dpc)
for the collection of 8-cell embryos and blastocysts. The 8-cell embryos and blastocysts were collected in M2 medium (Sigma-Aldrich, St. Louis, MO) from the oviduct and the uterus, respectively. These embryos were transferred to KSOM medium (Millipore) and cultured at 37°C in 5% CO 2 .
| Generation of chimeric mice using the embryo injection method
For blastocyst injections, approximately 10-15 rat ES cells were aspirated into an injection pipette and slowly injected into the mouse blastocyst using a piezo-assisted micromanipulator. After blastocyst injection, embryos were kept in KSOM medium until transfer. 
| Generation of chimeric mice by the aggregation method
Embryos at the 8-cell stage were briefly exposed to Tyrode's solution (Sigma-Aldrich) for removal of the zona pellucida.
After removal, the embryos were washed with M2 medium and transferred into a 60-mm dish containing small indentations. One or two embryos were placed into one indentation, and 10-20 rat ES cells were then added to each indentation. After co-culturing overnight, embryos were examined to confirm that the two embryos and the ES cells had aggregated into one embryo.
Approximately 14-16 embryos were transferred into the uteri of 2.5 dpc pseudopregnant recipient ICR mice mated with male C57BL/6 mice.
| Fluorescence imaging of organs in chimeric mice
Chimeric mice were initially identified by tdTOMATO fluorescence using a Leica M165 FC microscope (Leica Microsystems, Wetzlar, Germany). At 4 weeks of age, chimeric mice were euthanized, and the livers, lungs, pancreas, hearts, and kidneys were resected.
Fluorescence images were then obtained using the Leica M165
FC microscope. After imaging, each of these organs was cut in half. One half of each organ was embedded in an optimum cutting temperature (OCT) compound (Sakura Finetek, Tokyo, Japan) for immunohistochemistry, and the other half was used for genomic DNA extraction.
| Quantitative polymerase chain reaction
Genomic DNA was extracted using a QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions.
Quantitative polymerase chain reaction (qPCR) was performed using a KAPA SYBR FAST qPCR Kit (KAPA Biosystems, Wilmington, MA) and an Eco Real Time PCR System (Illumina, San Diego, CA). The oligonucleotide primers are presented in Table 1 . The contribution ratio of rat ES cell-derived cells was calculated based on the following formula.
[DNA] m0 , initial concentration of mouse genomic DNA; [DNA] r0 , initial concentration of rat genomic DNA; Cqm, threshold cycle of mouse; Cqr, threshold cycle of rat; e, PCR efficiency.
| Immunohistochemistry
Embedded organs were cut into 10-μm-thick sections using a cryostat at −20°C. Immunostaining was performed as previously reported. 20 In brief, slices were mounted on slides and dried for 30 min at room temperature. The slices were then fixed in 4% paraformaldehyde for 20 min at room temperature. After washing three times with PBS (-), the slices were activated by Immunosaver (dilution, 1:200; Nisshin EM, Tokyo, Japan) for 45 min at 98°C. 
| Statistical analysis
All data are expressed as mean ± SE. Statistical significance was assessed using one-way factorial analysis of variance with Tukey's HSD post hoc test for multiple comparisons using SPSS Statistics software version 18.0 (IBM Japan, Tokyo, Japan). All P-values <0.05
were considered to indicate a statistically significant difference in all analyses, and all were assessed with two-tailed tests.
| RE SULTS
| Generation of interspecies chimeric mice using rat ES cells
Interspecies chimeric mice were generated from mouse embryos and rat ES cells labeled with tdTOMATO (red fluorescence) by the
8-cell aggregation, 8-cell injection, or blastocyst injection method
( Figure 1A-D) . Fluorescence imaging of the body surface was performed to determine whether the newborn pups were chimeric.
Mice emitting red fluorescence were confirmed to be chimeras
TA B L E 1 Real-time PCR primer sequences Animals Gene Primer sequences
Mus musculus musculus Transferrin receptor (Tfr)
Forward:
( Figure 1E ). Successful chimeric mouse generation rates for the different methods were as follows: 8-cell aggregation (two embryos) (3.3%), 8-cell injection (4.7%), and blastocyst injection (12.5%) (Table 2 ). However, in the 8-cell aggregation (one-embryo) method, the birth rate was low, and chimeric mice could not be obtained.
Chimeric mice generated by the 8-cell aggregation (two embryos) method were used in subsequent experiments.
| Fluorescence imaging of chimeric mice organs
To determine the contribution of rat ES cells to individual organs, we isolated the liver, pancreas, heart, lungs, and kidneys from all non-chimeric and chimeric mice at 4 weeks of age and performed 
TA B L E 2 Generation of interspecies chimeric mice with rat ES cells using three different generation methods
Generation method Number of transplanted embryos
Borned mice
Number of pups
Number of non-chimeric mice
Number of chimeric mice F I G U R E 2 Contribution of rat ES cells to different organs in chimeric mice. The liver, pancreas, heart, lungs, and kidneys were harvested from nonchimeric and chimeric mice generated via 8-cell aggregation, 8-cell injection, and blastocyst injection. Whole organs were imaged for tdTOMATO expression, and tissue sections show the contribution of rat ES cells to the interior of the organs (counterstained with DAPI, blue)
were observed within the liver of chimeric mice generated by blastocyst injection.
| Contribution rate of rat ES cells in each organ
To more precisely determine the contribution of rat ES cells in each organ, we developed a calculation method based on qPCR analysis of genomic DNA. To confirm that the contribution rate was accurately calculated, we validated this method using genomic DNA extracted from samples in which rat ES cells and mouse ES cells were mixed at a known ratio. We then confirmed that the calculated contribution rate of rat ES cells was highly correlated with the theoretical contribution rate ( Figure 3A) .
In order to measure the contribution rate of rat ES cells in each organ, we homogenized the whole organ, except for the part necessary for embedding, and prepared genomic DNA (8-cell aggregation, n = 3; 8-cell injection, n = 6; blastocyst injection, n = 6). Analysis of genomic DNA obtained from the organs of chimeric mice showed that the contribution rate of rat ES cells in the liver was significantly increased by the 8-cell injection method as compared with blastocyst injection ( Figure 3B ). On the other hand, no significant difference was found in the contribution rate of rat ES cells for the other organs among the generation methods. Furthermore, the contribution of rat ES cells to the kidney was hardly found in any generation methods.
| Expression of rat CYP2C6 in the liver of chimeric mice
To determine whether the rat-derived liver cells were functional, we tested the production of the rat drug-metabolizing enzyme in 
| D ISCUSS I ON
In this study, we generated interspecies chimeric mice using three different methods: injection of 8-cell embryos and blastocysts, and aggregation of 8-cell embryos and rat ES cells. We found that injection of ES cells into blastocysts was the most effective means of generating chimeric mice (Table 2 ). However, the rat ES cell contribution rate measured by qPCR (8-cell aggregation, n = 3; 8-cell injection, n = 6; blastocyst injection, n = 6) differed depending on organs, but was higher in chimeras generated using 8-cell embryos than that of blastocyst ( Figure 3B ).
The reason for the low chimeric mouse generation rate using the 8-cell embryos seems straightforward: The ratio of rat ES cells to mouse cells is much higher in 8-cell embryos than in blastocysts, which contain 32-64 cells. Moreover, the birth rate in one-embryo aggregation was worse than that in two-embryo aggregation (Table 2 ). Since we used the same number of rat ES cells in one-embryo aggregation and two-embryo aggregation, there is a possibility that the contribution of rat ES cells could be higher in one-embryo aggregation. It has been reported that the high contribution of interspecies cells is associated with malformation and reduction in their survival rate. 9, 18 In this study, when we isolated the uterus of female mice after birth, embryos whose development was stopped halfway were observed ( Figure 5 ). We suspect that the high rat ES cell contribution rate and the early developmental stage of the recipient embryos may inhibit the development of chimeric embryos in utero.
It may be possible to prevent this inhibition of chimera development by using gene editing technologies such as CRISPR/Cas9 to inhibit the differentiation of PSCs into other than the target organ.
Generally, the ES cell contribution rate is determined by immunostaining organ sections in chimeric mice and calculating the ratio of rat-derived cells in a defined area. However, this method is laborintensive, and the contribution rate can only be determined for part of an organ. Thus, the contribution rate calculated using this method may not accurately reflect the contribution in the whole organ.
Furthermore, the contribution of rat ES cells in the organs of the chimeric mice is not uniform; that is, the calculated contribution rate in one organ cannot be applied to other tissues. To solve this problem, we used a novel method utilizing genomic DNA extracted from each organ of chimeric mice. We found a high correlation between F I G U R E 3 Calculation of the rate of contribution of rat ES cells to the organs of chimeric mice. A, Validation of the contribution rate calculation method. B, The contribution rate of rat ES cells in each organ. The results are presented as mean ± SE (8-cell aggregation, n = 3; 8-cell injection, n = 6; blastocyst injection, n = 6). **P < 0.01, Tukey's HSD test
Immunostaining of chimeric mouse liver sections with anti-rat CYP2C6 antibody. The livers of two chimeric mice, created using different methods, were immunostained, and the representative results are shown the calculated rate and the theoretical contribution rate using this method ( Figure 3A) , which indicated that the calculated contribution rates are accurate. This method allows us to easily calculate the proportion of heterogeneous cells in whole organs without immunostaining. Nevertheless, in this method, it is necessary to extract DNA from whole organ to accurately measure chimerism, and it is difficult to apply this method to larger animals. In the future, it is necessary to further improve the analysis of chimerism rate.
We found that rat ES cells contributed to all of the organs tested with the exception of the kidney, where rat ES cells were hardly detectable, regardless of the chimera generation method (Figures 2 and 3B). A recent study reported the generation of PSC-derived kidneys by blastocyst complementation using mouse PSCs and Sall1 −/− mouse embryos, which are unable to form kidneys. 21 This report indicated that rat PSCs could not be used to generate the kidney in mice due to deficient cell-to-cell interactions in the early stages of kidney development, which is consistent with our results (Figures 2   and 3B ).
In the liver, the contribution of rat ES cells was significantly higher in chimeras generated by the 8-cell injection method, whereas contributions were barely detected in chimeras generated by blastocyst injection. The contribution of rat ES cells in the liver of chimeric mice generated by 8-cell injection method was higher than that in the pancreas of chimeric mice generated by blastocyst injection. Furthermore, we found that the drug-metabolizing enzyme CYP2C6 was expressed by rat hepatocytes in chimeras generated by either the 8-cell aggregation or 8-cell injection techniques ( Figure 4 ).
Our results suggest that the liver can be generated using the complementation method with 8-cell embryos, similar to the recent report of rat iPS cell-derived pancreatic islets generated by blastocyst complementation. 9 However, a "master gene" controlling liver development has not been identified, and thus, there is no genetic mouse model that exhibits liver agenesis and could be used for complementation experiments. Instead, it may be possible to increase the contribution of ES cell-derived hepatocytes in the liver by using mice in which hepatitis is induced after birth, such as hepatocytespecific herpes simplex virus type 1 thymidine kinase expressing mice (ALB-TK mice), fumarylacetoacetate hydrolase knockout mice (Fah −/− mice), and urokinase-type plasminogen activator-transgenic mice (uPA mice). [22] [23] [24] In summary, while our current results are promising, it remains to be seen whether functional organs derived from PSCs can be generated using 8-cell embryo complementation similarly to blastocyst complementation. The influence of chimeric animal generation method on the contribution of PSCs in rat-mouse ES cells chimeras and chimeric animals among other animal species should be examined in the future.
The contribution rate of rat ES cells in chimeras generated by blastocyst injection was substantially different between organs, while that in 8-cell injection was relatively uniform except, for the kidneys ( Figure 3B ). It has been reported that blastomeres in 8-cell embryos are pluripotent and can contribute to all tissues. [25] [26] [27] On the other hand, cells in the ICM of the blastocyst have already begun to differentiate and will develop into spatially distinct epiblast and primitive endoderm as the blastocyst develops. [28] [29] [30] In embryos injected at the 8-cell stage, rat ES cells grow alongside the blastomeres of the host fertilized egg and thus contribute uniformly to the ICM. However, it is likely that the rat ES cells are not evenly distributed in the ICM of injected blastocysts, and this may account for the differences in rat ES cell contributions among the different organs.
In summary, we revealed that 8-cell injection significantly increased the contribution of rat ES cells in the liver of chimeric mice and generated functional rat ES cell-derived hepatocytes. We conclude that 8-cell injection is the most useful method for generating chimeric organs, particularly the liver, from PSCs using chimeric animal generation. We expect that our findings with facilitate research on liver generation in interspecific chimeric animals, making clinical application of this technique possible in the future.
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